Article citationsMore>>

Bhananker, S.M., O’Donnell, J.T., Salemi, J.R. and Bishop, M.J. (2005) The Risk of Anaphylactic Reactions to Rocuronium in the United States Is Comparable to That of Vecuronium: An Analysis of Food and Drug Administration Reporting of Adverse Events. Anesthesia & Analgesia, 101, 819-822.
http://dx.doi.org/10.1213/01.ANE.0000175213.87556.D8

has been cited by the following article:

• TITLE: Sugammadex in the Management of Sinus Tachycardia after Rocuronium Administration: A Case Report

  AUTHORS: Eduardo Fernandes Orioli Guimarães, Muriel Mofreita Saldanha, Tiago Coelho Fortes, Marcelo Grisolia, Marcos Lopes de Miranda, Carlos Darcy Alves Bersot

  KEYWORDS: Rocuronium, Sugammadex, Anesthesia, Sinus Tachycardia

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.4 No.9, September 12, 2014

  ABSTRACT: In rare cases, rocuronium has been associated with dose-related tachycardia, probably by a cardiac muscarinic M2 receptor blockade mechanism. We report the case of a 30-year-old female who underwent excision of a branchial cyst under general anesthesia. This patient presented an episode of sinus tachycardia (130 bpm) shortly after anesthesia induction with propofol, sufentanyl, and rocuronium. Tachycardia could not be explained by any cause other than the use of rocuronium, which was reverted with sugammadex. Two minutes after sugammadex administration, heart rate normalized, corroborating our hypothesis that rocuronium induced the sinus tachycardia observed in our patient. The patient recovered well from the anesthetic-surgical procedure and showed no further cardiovascular, ventilatory, or neurological changes, being transferred to the post-anesthesia care unit, and finally discharged to the ward.